The global life science logistics market is witnessing a significant transformation with increasing demand for the safe and timely delivery of pharmaceutical and biological products. According to recent data, the market size reached USD 127.7 billion in 2024, expanded to USD 137.23 billion in 2025, and is forecasted to grow to approximately USD 262.51 billion by 2034 at a CAGR of 7.46%.
🌍 Market Overview
With the growing importance of cold chain management and the complex requirements for transporting temperature-sensitive biologics, vaccines, and insulin, the logistics sector is rapidly adapting to meet global healthcare demands. The rise of AI, machine learning, and automation is further enhancing operational efficiency in clinical trials and biopharma shipments.
📌 Key Market Highlights
-
Market Size: USD 127.7 billion (2024), projected to reach USD 262.51 billion by 2034.
-
CAGR: 7.46% (2025–2034)
-
Top Region: North America held a 38% share in 2024.
-
Fastest Growth: Asia Pacific is set to lead in CAGR.
-
Dominant Service Segment: Transportation services held 55% of global revenue share in 2024.
🏢 Leading Life Science Logistics Companies in 2025
1. DHL Supply Chain
-
About: A global leader in supply chain solutions, DHL offers tailored services for life sciences and healthcare logistics.
-
Products/Services: Cold chain logistics, clinical trial logistics, packaging.
-
Market Cap: Part of Deutsche Post DHL Group, with a market cap of over USD 60 billion.
2. UPS Healthcare
-
About: A specialized division of UPS, focusing on healthcare supply chain management.
-
Products/Services: Cold chain solutions, tracking systems, warehouse management.
-
Market Cap: Parent company UPS has a market cap of around USD 120 billion.
3. Kuehne+Nagel
-
About: A Swiss logistics company with a strong focus on pharmaceutical logistics.
-
Products/Services: GDP-compliant transport, warehousing, temperature monitoring.
-
Market Cap: Estimated at USD 27 billion.
4. FedEx Express
-
About: A global courier company offering advanced logistics services for healthcare and pharma.
-
Products/Services: Overnight delivery, temperature-controlled shipping, FedEx SenseAware.
-
Market Cap: Over USD 66 billion.
5. DB Schenker Life Science Logistics
-
About: DB Schenker provides global logistics solutions tailored to pharmaceutical and biotech companies.
-
Products/Services: Warehousing, last-mile delivery, GDP compliance.
-
Market Cap: Owned by Deutsche Bahn, estimated valuation exceeds USD 25 billion.
6. CEVA Logistics (CMA CGM Group)
-
About: A leading logistics and freight forwarding firm under CMA CGM Group.
-
Products/Services: Cold chain, pharma logistics, customs compliance.
-
Market Cap: CMA CGM estimated privately-held valuation over USD 80 billion.
7. Agility Logistics
-
About: A Kuwait-based supply chain services company with a strong life sciences vertical.
-
Products/Services: Cold storage, last-mile delivery, customs clearance.
-
Market Cap: Publicly traded, valued around USD 5 billion.
8. Marken (UPS Subsidiary)
-
About: A key clinical trial logistics provider acquired by UPS.
-
Products/Services: Direct-to-patient shipments, clinical trial material handling.
-
Market Cap: Operates under UPS Healthcare’s umbrella.
9. Cryoport, Inc.
-
About: Specializes in temperature-controlled logistics for cell and gene therapies.
-
Products/Services: Cryogenic packaging, chain-of-condition monitoring.
-
Market Cap: Around USD 400 million.
10. World Courier (AmerisourceBergen)
-
About: Offers premium logistics for pharma, especially investigational products.
-
Products/Services: Time-critical deliveries, ambient and frozen supply chains.
-
Market Cap: AmerisourceBergen has a market cap exceeding USD 45 billion.
11. Biocair
-
About: A UK-based specialist in temperature-sensitive biological logistics.
-
Products/Services: Clinical trial shipping, cold chain services.
-
Market Cap: Privately held; part of the DPD Group.
12. GEODIS
-
About: A French logistics company offering supply chain optimization for life sciences.
-
Products/Services: Transport, contract logistics, 4PL solutions.
-
Market Cap: State-owned by SNCF Group, indirect valuation USD 8–10 billion.
13. Catalent Pharma Solutions
-
About: Leading provider of advanced delivery technologies and development solutions.
-
Products/Services: Clinical supply services, packaging, storage.
-
Market Cap: Around USD 8.5 billion.
14. Movianto (Walden Group)
-
About: Specializes in healthcare logistics in Europe.
-
Products/Services: Cold chain storage, national distribution, regulatory support.
-
Market Cap: Private company; estimated value USD 1–2 billion.
15. Yusen Logistics
-
About: Japanese global logistics provider with healthcare logistics as a core vertical.
-
Products/Services: Pharma-grade warehouses, refrigerated trucking, sea/air forwarding.
-
Market Cap: Over USD 4 billion.
16. Zuellig Pharma
-
About: One of the largest healthcare services groups in Asia.
-
Products/Services: Cold chain logistics, distribution, healthcare data analytics.
-
Market Cap: Private company; valuation estimated over USD 15 billion.
Request a customized case study tailored to your business needs and gain deeper insights
into healthcare market strategies: sales@towardshealthcare.com
❓ Frequently Asked Questions (FAQs)
1. What is life science logistics?
Life science logistics refers to the specialized transportation and storage of pharmaceuticals, biologics, medical devices, and clinical trial materials, often requiring temperature-controlled conditions.
2. Why is cold chain logistics important in life sciences?
Cold chain solutions ensure temperature-sensitive products like vaccines, insulin, and biologics remain effective and safe from manufacturer to end user.
3. Which region leads the life science logistics market?
North America dominated the market in 2024 with a 38% share, while Asia Pacific is projected to be the fastest-growing region.
4. How are technologies like AI and ML used in this industry?
AI and ML help optimize routing, predict demand, manage inventory, and monitor temperature and product conditions in real time.
5. Which segment dominates the life science logistics service market?
The transportation segment leads with about 55% of the revenue share due to the critical need for safe, compliant, and timely delivery.
Source : https://www.towardshealthcare.com/insights/life-science-logistics-market-sizing
Invest in Our Premium Strategic Solution: https://www.towardshealthcare.com/price/5890
About the Author
